CARA - Cara Therapeutics Inc. (CARA) CEO Chris Posner on Q1 2022 Results - Earnings Call Transcript

Cara Therapeutics, Inc. (CARA) Q1 2022 Earnings Conference Call May 09, 2022 04:30 PM ET Company Participants Iris Francesconi - Interim Head, Investor Relations Chris Posner - President & Chief Executive Officer Tom Reilly - Chief Financial Officer Joana Goncalves - Chief Medical Officer. Conference Call Participants Joseph Stringer - Needham & Company Chi Tran - Bank of America Daniel Wolle - JPMorgan David Amsellem - Piper Sandler Sumant Kulkarni - Canaccord Oren Livnat - H.C. Wainwright Presentation Operator Good afternoon. My name is May, and I will be your conference facilitator. I would like to welcome everyone to the Cara Therapeutics First Quarter 2022 Financial Results and Update Conference Call. All lines have been placed on mute to avoid any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Please be advised that this call is being recorded. I would now like to introduce

For further details see:

Cara Therapeutics, Inc. (CARA) CEO Chris Posner on Q1 2022 Results - Earnings Call Transcript